查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2009413

静脉输液市场规模、份额、趋势和预测：按类型、营养成分和地区划分，2026-2034年

Intravenous Solutions Market Size, Share, Trends and Forecast by Type, Nutrients, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

2025年全球静脉输液市场规模为163亿美元。展望未来，IMARC集团预测，该市场将以4.30%的复合年增长率从2026年增长至2034年，到2034年达到238亿美元。目前，北美市场占据主导地位，预计2025年市占率将超过40.7%。北美地区的成长主要得益于先进的医疗基础设施、慢性病盛行率的上升以及老年人口的成长。

糖尿病、癌症和肾臟病等慢性疾病发生率的上升，增加了对静脉输液（IV）疗法的需求。静脉输液疗法可将液体、营养物质和药物直接输送到血液中。这些治疗方法对于控制併发症和改善短期和长期照护机构中患者的预后至关重要。此外，老年人口的不断增长，以及因脱水和免疫功能减弱等与老龄化相关的问题而需要重症监护的患者，也推动了对能够有效解决这些问题的静脉输液疗法的需求。同时，静脉输液疗法的持续进步，包括精确控制的给药系统、患者特异性营养配方和增强的安全措施，正在提高治疗效果。这些进展使得能够提供满足患者个别需求的客製化解决方案，从而提升整体医疗服务品质。此外，因胃肠道疾病或其他严重健康状况而无法经口进食的患者，也依赖静脉输液疗法来获得充足的营养。这种需求正在推动改良型肠外营养配方的研发和应用。

美国是该市场的重要组成部分。这主要源自于越来越多的手术需要静脉输液来维持水合作用、麻醉和术后恢復。此外，天灾等事件会扰乱供应链，凸显稳定供应静脉输液的重要性。为了应对这项挑战，各公司正在扩大产能，并与监管机构和政府部门合作，以确保基本医疗产品的稳定供应。这些努力有助于稳定市场供应，维持医疗运营，并有效应对不断增长的需求。 2024年，受飓风造成的生产中断影响，贝朗公司宣布采取措施保障美国静脉输液的供应。该公司扩大了位于加州、佛罗里达州和宾州的工厂的生产规模，使静脉输液产量提高了20%，静脉输液套装的年产量增加了3000多万套。此外，该公司还与联邦机构合作，节约并重新分配关键库存。

静脉输液市场趋势：

慢性病增多

糖尿病、心臟病、癌症等慢性疾病以及需要静脉输液治疗的严重发生率不断上升，是推动市场成长的关键因素。根据国际糖尿病联盟（IDF）统计，2021年英国有2,680,500名成年人被诊断出患有糖尿病。此外，根据美国疾病管制与预防中心（CDC）统计，2021年美国有1,777,566人被诊断出罹患癌症。同时，生活方式改变、环境因素和遗传因素等全球趋势也加剧了慢性疾病的发生，促进了市场成长。此外，各种急性和慢性疾病都需要将液体、营养素或药物直接输注到血液中。在这方面，静脉输液治疗能够精准地输送维持生命的营养物质和药物，促进患者快速康復。此外，它还能提供更快速、更可控的治疗，尤其是在紧急情况下。

人口老化的过程

老年人口的成长对静脉输液治疗市场的发展起了至关重要的作用。根据美国社区生活部 (ACL) 统计，2021 年至 2022 年间，美国约有 160 万名 65 岁及以上的老年人。老年人更容易患上各种健康问题和慢性疾病，并且经常需要进行复杂的医疗程序，例如静脉输液治疗，这推动了市场成长。此外，与年龄相关的生理变化，例如免疫功能减弱、器官功能下降老龄化，增加了老年人感染疾病和疾病的风险，也促进了市场成长。在此背景下，静脉输液治疗对于确保输送必要的液体、营养和药物至关重要，从而确保治疗的准确性和有效性。此外，静脉输液治疗在纠正电解质失衡（包括钠、钾、钙和镁）方面的广泛应用也是推动市场成长的另一个重要因素。

技术进步

医疗技术和静脉製剂生产的进步正在推动市场成长。新兴技术提高了静脉治疗的效率和安全性，同时促进了更个人化製剂的研发，以满足每位患者的个别需求。此外，输液帮浦和给药系统的最新进展，使医护人员能够更精准、更有效地进行治疗，也促进了市场扩张。同时，静脉治疗监测和给药技术的进步，降低了併发症风险，改善了患者预后，也是推动市场成长的另一个动力。此外，大规模的研发投入，例如生物相容性、个人化治疗策略和人工智慧（AI）等技术的引入，旨在改善医疗服务，也促进了市场成长。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球静脉输液市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场区隔：按类型
  • 市场区隔：依营养成分划分
  • 市场区隔：按地区
  • 市场预测
  • SWOT分析
  • 价值链分析
  • 波特五力分析

第六章 市场区隔：依类型

  • 部分肠外营养
  • 全静脉营养

第七章 市场区隔：依营养素划分

  • 碳水化合物
  • 盐和电解质
  • 矿物
  • 维他命
  • 胺基酸

第八章 市场区隔：依地区划分

  • 北美洲
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 拉丁美洲

第九章：静脉输液生产工艺

第十章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Ajinomoto
    • B. Braun Melsungen
    • Baxter International Inc.
    • Grifols
    • Otsuka Pharmaceutical
Product Code: SR112026A891

The global intravenous solutions market size was valued at USD 16.3 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 23.8 Billion by 2034, exhibiting a CAGR of 4.30% from 2026-2034. North America currently dominates the market, holding a market share of over 40.7% in 2025. The growth of the North American region is driven by advanced healthcare infrastructure, rising chronic disease prevalence, and increasing elderly population.

The rising incidence of chronic diseases such as diabetes, cancer, and kidney issues is driving the demand for intravenous (IV) therapy to provide hydration, nutrients, and medications straight into the bloodstream. These solutions are crucial for handling complications and enhancing patient outcomes in both short-term and long-term care environments. Additionally, the increasing elderly demographic, needing critical care because of age-related issues such as dehydration and compromised immune systems, is catalyzing the demand for IV solutions to tackle these problems efficiently. In addition to this, ongoing advancements in IV therapy, including precision-managed delivery systems, tailored nutrient mixes, and enhanced safety measures, are boosting the effectiveness of treatments. These developments enable customized solutions to address specific patient requirements, enhancing the overall quality of healthcare services. Moreover, patients who cannot eat by mouth, such as those with gastrointestinal issues or serious health conditions, depend on intravenous solutions for full nutrition. This need propels the creation and use of enhanced parenteral nutrition formulations.

The United States is a vital segment in the market, supported by the rising volume of surgeries conducted, which necessitate IV solutions to ensure hydration, administer anesthesia, and aid in post-operative recovery. In addition, occurrences such as natural disasters can interrupt supply chains, emphasizing the significance of a strong IV solution supply. In response, companies boost production capacities and partner with regulatory and government bodies to guarantee a steady supply of essential medical products. These efforts help stabilize market availability, maintain healthcare operations, and meet growing demand effectively. In 2024, B. Braun announced efforts to secure IV fluid supplies in the US after hurricanes disrupted production. The company ramped up manufacturing at facilities in California, Florida, and Pennsylvania, boosting IV fluid production by 20% and IV sets by over 30 million annually. They also collaborated with federal agencies to safeguard and redistribute critical inventory.

INTRAVENOUS SOLUTIONS MARKET TRENDS:

Increasing Prevalence of Chronic Conditions

The increased occurrence of chronic illnesses like diabetes, heart diseases, cancer, and severe conditions requiring IV therapies is a key element driving the growth of the market. As per the International Diabetes Federation, there were 2,680,500 adults diagnosed with diabetes in the UK in 2021. Moreover, the Centers for Disease Control and Prevention reported that in 2021, 1,777,566 individuals in the US population received a cancer diagnosis. Additionally, rising global trends like shifts in lifestyle, environmental influences, and genetic factors that contribute to a rise in chronic diseases serve as another catalyst for growth. Besides this, various chronic and acute conditions necessitate the direct infusion of fluids, nutrients, or medications into the bloodstream. In this regard, IV solutions enable accurate administration of vital nutrients and medications, promoting swift patient recovery. Moreover, they facilitate quicker and more regulated care, especially in urgent circumstances.

Growing Geriatric Population

The rising elderly population is playing a major role in the growth of the IV solutions market. The Administration for Community Living (ACL) reported that from 2021 to 2022, 1.6 million Americans were noted to be aged 65 or older. The increased vulnerability of the elderly to numerous health problems and chronic ailments, which frequently necessitate intricate medical treatments like IV therapy, is supporting the market growth. In addition, the existence of a compromised immune system, diminished organ performance, and other age-associated physiological alterations that increase the vulnerability of elderly individuals to infections and illnesses are contributing to the market growth. In this context, IV solutions are crucial for delivering necessary hydration, nutrients, and medications, making certain that the treatments are precise and effective. Additionally, the extensive use of IV solutions to correct imbalances in electrolytes like sodium, potassium, calcium, and magnesium is serving as another catalyst for growth.

Technological Advancements

Improvements in medical technology and the manufacturing of IV solutions are strengthening the growth of the market. In this regard, emerging technologies are facilitating the development of more tailored solutions that address particular patient requirements while improving the efficiency and safety of IV treatments. Moreover, the latest advancements in infusion pumps and delivery systems, enabling healthcare professionals to provide treatments with enhanced accuracy and control, are benefiting the market expansion. Furthermore, advancements in technology for overseeing and administering IV therapies to reduce the risk of complications and enhance patient outcomes are serving as another factor driving growth. In addition, considerable research and development (R&D) initiatives concentrating on biocompatibility, tailored treatment strategies, and the incorporation of technology like artificial intelligence (AI) to enhance care are propelling the market growth.

INTRAVENOUS SOLUTIONS INDUSTRY SEGMENTATION:

Analysis by Type:

  • Partial Parenteral Nutrition
  • Total Parenteral Nutrition

Total parenteral nutrition stands as the largest segment in 2025, holding 77.7% of the market share. Total parenteral nutrition (TPN) is leading the market as it addresses all the dietary needs of patients unable to consume or absorb sufficient food through normal digestive processes. Moreover, it has wide-ranging uses in several medical areas, such as oncology, gastroenterology, and intensive care units (ICUs). Besides this, the increasing prevalence of chronic illnesses like cancer and gastrointestinal disorders that require TPN for nutritional assistance is driving market expansion. Additionally, the rising use of TPN to address the nutritional requirements of patients undergoing significant surgical operations is driving market expansion. In addition, the advancements in TPN formulation and delivery technology, which provide safer and more individualized nutritional support, are contributing to the market growth.

Analysis by Nutrients:

  • Carbohydrates
  • Salts and Electrolytes
  • Minerals
  • Vitamins
  • Amino Acids

Amino acids lead the market with 36.8% of market share in 2025. Amino acids represent the largest segment, primarily due to their critical role in supporting protein synthesis, wound healing, and overall metabolic function. These essential nutrients are particularly vital for patients unable to consume adequate protein through oral or enteral routes, such as those undergoing major surgeries, suffering from trauma, or dealing with chronic illnesses like cancer and renal disorders. Amino acid-based IV solutions are widely used in TPN where they ensure the delivery of essential building blocks for maintaining muscle mass, immune function, and cellular repair. Advances in formulations tailored for specific patient needs, including pediatric and geriatric care, have further bolstered demand for amino acid solutions. Additionally, the increasing focus on personalized nutrition in clinical settings ensures that amino acids remain a cornerstone in intravenous therapy, making them the dominant choice among nutrients in the segment. This trend reflects their indispensable role in critical care and recovery.

Regional Analysis:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

In 2025, North America accounted for the largest market share of 40.7%. North America holds the biggest share in the market, supported by its sophisticated healthcare system and a significant incidence of chronic illnesses like diabetes, cancer, and heart diseases. The increasing elderly demographic in the area, who are more susceptible to dehydration and need essential medical care, greatly drives the need for intravenous therapies. Hospitals, outpatient clinics, and home care services depend on IV therapy to provide vital nutrients, medications, and hydration, thereby enhancing the market. Moreover, the extensive use of advanced technologies in IV solutions, including precision-controlled delivery systems, improves their application in intricate medical therapies. Collaborations among major industry stakeholders facilitate the sharing of resources, knowledge, and technologies to address increasing demand and enhance production efficiency. These collaborations also foster innovation in IV formulations, addressing evolving healthcare needs across the region. In November 2024, ICU Medical and Otsuka Pharmaceutical Factory announced a joint venture to enhance IV solutions manufacturing in North America, combining their expertise to produce 1.4 billion units annually. This partnership aims to strengthen supply chain resiliency and accelerate innovation in IV solutions for the region.

KEY REGIONAL TAKEAWAYS:

UNITED STATES INTRAVENOUS SOLUTIONS MARKET ANALYSIS

In North America, the United States accounted for 92.80% of the total market share. The increasing prevalence of chronic diseases across the nation such as diabetes, hypertension, and cancer are driving the demand for IV fluids. According to the International Diabetes Federation, in 2021, 237,306,100 number of the American population is suffering from diabetes. Additionally, according to the Centers for Disease Control and Prevention, between 2021 and 2023, 47.7% of the adults suffered from hypertension in USA. Moreover, the rate of hypertension was higher among men than among women. 50.8% of men and 44.6% of women had hypertension. In line with this, the growing number of elderly people who are often requiring IV treatments for hydration and nutrition is propelling the market for it. According to Censes Bureau, over the past century, from 1920 to 2020, the U.S. population aged 65 and above expanded at a rate nearly five times faster than the overall population. In 2020, the geriatric demographic reached 55.8 Million, accounting for 16.8% of the total U.S. population.

EUROPE INTRAVENOUS SOLUTIONS MARKET ANALYSIS

The intravenous solutions market across the European region is largely driven due to rising requirement of intravenous fluid administration for dehydration or illnesses like diarrhea or gastroenteritis, leading to significant demand for IV solutions especially among children. Additionally, the expanding healthcare infrastructure, especially in Eastern Europe, is contributing to the market growth. According to the European Commission, Germany boasts one of the largest hospital inpatient sectors in the EU, with 7.9 hospital beds per 1,000 people-significantly surpassing the EU average of 5.3 beds by 50%. In line with this, the increasing focus on providing nutritional support to patients who are unable to consume food orally is driving the demand for parenteral nutrition solutions across the region, which are being delivered intravenously. With the growing preference for home-based healthcare, especially in managing chronic conditions or post-surgical recovery, there is an increase in demand for home IV therapy solutions that are being delivered intravenously.

ASIA PACIFIC INTRAVENOUS SOLUTIONS MARKET ANALYSIS

Due to fast urbanization and rising healthcare requirements, especially in India and China, there is a strong demand for intravenous solutions in hospitals and clinics, particularly in rural and remote locations. For example, the International Trade Administration reports that by 2021, China set up a network of 36,570 hospitals, offering over 7.4 million beds and serving around 3.88 billion patient visits. Additionally, in nations like India and Southeast Asia, IV fluids are utilized for treating dehydration from infectious diseases like diarrhea and cholera, which are common in these areas. For example, the CDC states that travelers' diarrhea is the most prevalent illness associated with travel. These have the greatest risk in areas like Asia (excluding Japan and South Korea) and also the Middle East, Africa, Mexico, and Central and South America, consequently increasing the need for intravenous solutions.

LATIN AMERICA INTRAVENOUS SOLUTIONS MARKET ANALYSIS

In urban areas of Brazil, IV solutions are widely utilized in emergency departments, intensive care units, and trauma services. The rising incidence of chronic conditions such as diabetes and heart diseases is driving the need for IV solutions for hydration and medication delivery. The International Diabetes Federation reports that in 2021, 149,916,800 individuals in Brazil are affected by diabetes. In this context, the thriving medical tourism sector is promoting the utilization of IV solutions for numerous treatments, such as recovery after surgery and wellness therapies.

MIDDLE EAST AND AFRICA INTRAVENOUS SOLUTIONS MARKET ANALYSIS

Due to various factors, the need for intravenous solutions is increasing throughout the Middle East and Africa region. Increasing quantity of intravenous solutions are majorly used across the Gulf Cooperation Council (GCC) countries for the management of diabetes and renal diseases. According to the International Diabetes Federation, in 2021, 8,057,100 number of adults in the United Arab Emirates were diagnosed with diabetes. Moreover, 73 Million people are already diagnosed with diabetes across the MENA region. In line with this, intravenous solutions are increasingly used in conflict-affected and disaster-prone areas across the region for rehydration and medication.

COMPETITIVE LANDSCAPE:

Key players in the market are focusing on expanding their product portfolios through innovation and advanced formulations tailored to diverse medical needs. They are investing in research operations to improve solution stability, enhance nutrient delivery, and address specific patient conditions. Companies are also optimizing manufacturing processes to meet stringent regulatory requirements while ensuring cost-efficiency. Additionally, they are leveraging digital technologies for precision delivery and monitoring systems, aiming to improve patient outcomes. Market leaders are actively targeting emerging regions to capture growth opportunities and expand their user base. Strategic partnerships, mergers, and acquisitions are enhancing their worldwide presence and supply chain strengths. In May 2023, Intellego Technologies and HAI Solutions were pleased to announce a strategic partnership that aimed to enhance the quality and safety of intravenous (IV) vascular access. This partnership brought Intellego's patented UV-sensitive ink as an integral indicator into HAI Solutions' QIKcap(TM) technology, providing visible and reliable verification of IV port protection. The combined solution ensures confidence in the disinfection of needle-free connectors.

The report provides a comprehensive analysis of the competitive landscape in the intravenous solutions market with detailed profiles of all major companies, including:

  • Ajinomoto
  • B. Braun Melsungen
  • Baxter International Inc.
  • Grifols
  • Otsuka Pharmaceutical

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What are intravenous solutions?

2. How big is the global intravenous solutions market?

3. What is the expected growth rate of the global intravenous solutions market during 2026-2034?

4. What are the key factors driving the global intravenous solutions market?

5. What is the leading segment of the global intravenous solutions market based on type?

6. What is the leading segment of the global intravenous solutions market based on nutrients?

7. What are the key regions in the global intravenous solutions market?

8. Who are the key players/companies in the global intravenous solutions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous Solutions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type
  • 5.5 Market Breakup by Nutrients
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast
  • 5.8 SWOT Analysis
    • 5.8.1 Overview
    • 5.8.2 Strengths
    • 5.8.3 Weaknesses
    • 5.8.4 Opportunities
    • 5.8.5 Threats
  • 5.9 Value Chain Analysis
    • 5.9.1 Overview
    • 5.9.2 Research and Development
    • 5.9.3 Raw Material Procurement
    • 5.9.4 Manufacturing
    • 5.9.5 Marketing
    • 5.9.6 Distribution
    • 5.9.7 End-Use
  • 5.10 Porters Five Forces Analysis
    • 5.10.1 Overview
    • 5.10.2 Bargaining Power of Buyers
    • 5.10.3 Bargaining Power of Suppliers
    • 5.10.4 Degree of Competition
    • 5.10.5 Threat of New Entrants
    • 5.10.6 Threat of Substitutes

6 Market Breakup by Type

  • 6.1 Partial Parenteral Nutrition
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Total Parenteral Nutrition
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Nutrients

  • 7.1 Carbohydrates
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Salts and Electrolytes
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Minerals
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Vitamins
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Amino Acids
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Intravenous Solutions Manufacturing Process

  • 9.1 Product Overview
  • 9.2 Raw Material Requirements
  • 9.3 Manufacturing Process
  • 9.4 Key Success and Risk Factors

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Ajinomoto
      • 10.3.1.1 Company Overview
      • 10.3.1.2 Description
      • 10.3.1.3 Product Portfolio
      • 10.3.1.4 Financials
      • 10.3.1.5 SWOT Analysis
    • 10.3.2 B. Braun Melsungen
      • 10.3.2.1 Company Overview
      • 10.3.2.2 Description
      • 10.3.2.3 Product Portfolio
      • 10.3.2.4 Financials
      • 10.3.2.5 SWOT Analysis
    • 10.3.3 Baxter International Inc.
      • 10.3.3.1 Company Overview
      • 10.3.3.2 Description
      • 10.3.3.3 Product Portfolio
      • 10.3.3.4 Financials
      • 10.3.3.5 SWOT Analysis
    • 10.3.4 Grifols
      • 10.3.4.1 Company Overview
      • 10.3.4.2 Description
      • 10.3.4.3 Product Portfolio
      • 10.3.4.4 Financials
      • 10.3.4.5 SWOT Analysis
    • 10.3.5 Otsuka Pharmaceutical
      • 10.3.5.1 Company Overview
      • 10.3.5.2 Description
      • 10.3.5.3 Product Portfolio

List of Figures

  • Figure 1: Global: Intravenous Solutions Market: Major Drivers and Challenges
  • Figure 2: Global: Intravenous Solutions Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Intravenous Solutions Market: Breakup by Type (in %), 2025
  • Figure 4: Global: Intravenous Solutions Market: Breakup by Nutrients (in %), 2025
  • Figure 5: Global: Intravenous Solutions Market: Breakup by Region (in %), 2025
  • Figure 6: Global: Intravenous Solutions Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 7: Global: Intravenous Solutions Industry: SWOT Analysis
  • Figure 8: Global: Intravenous Solutions Industry: Value Chain Analysis
  • Figure 9: Global: Intravenous Solutions Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Intravenous Solutions (Partial Parenteral Nutrition) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Intravenous Solutions (Partial Parenteral Nutrition) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Intravenous Solutions (Total Parenteral Nutrition) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Intravenous Solutions (Total Parenteral Nutrition) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Intravenous Solutions (Carbohydrates) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Intravenous Solutions (Carbohydrates) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Intravenous Solutions (Salts and Electrolytes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Intravenous Solutions (Salts and Electrolytes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Intravenous Solutions (Minerals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Intravenous Solutions (Minerals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Intravenous Solutions (Vitamins) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Intravenous Solutions (Vitamins) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Intravenous Solutions (Amino Acids) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Intravenous Solutions (Amino Acids) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: North America: Intravenous Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: North America: Intravenous Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Europe: Intravenous Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Europe: Intravenous Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Asia Pacific: Intravenous Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Asia Pacific: Intravenous Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Middle East and Africa: Intravenous Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Middle East and Africa: Intravenous Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Latin America: Intravenous Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Latin America: Intravenous Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Intravenous Solutions Manufacturing: Detailed Process Flow

List of Tables

  • Table 1: Global: Intravenous Solutions Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Intravenous Solutions Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Intravenous Solutions Market Forecast: Breakup by Nutrients (in Million USD), 2026-2034
  • Table 4: Global: Intravenous Solutions Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Intravenous Solutions: Raw Material Requirements
  • Table 6: Global: Intravenous Solutions Market: Competitive Structure
  • Table 7: Global: Intravenous Solutions Market: Key Players